本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

104.31
+3.923.90%
盤後102.31-2.0000-1.92%18:56 EDT
成交量:81.22萬
成交額:8,358.56萬
市值:66.56億
市盈率:-50.88
高:105.00
開:99.42
低:97.16
收:100.39
52周最高:105.69
52周最低:39.60
股本:6,380.87萬
流通股本:4,315.48萬
量比:0.52
換手率:1.88%
股息:- -
股息率:- -
每股收益(TTM):-2.0500
每股收益(LYR):-2.0500
淨資產收益率:-20.18%
總資產收益率:-13.99%
市淨率:10.83
市盈率(LYR):-50.88

資料載入中...

2026/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities